Trial Profile

Human bioavailability study of benznidazole for treatment of Chagas disease, a neglected tropical disease.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 14 Aug 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Benznidazole (Primary)
Indications Chagas disease
Focus Pharmacokinetics
Sponsors Humanigen

Most Recent Events

14 Aug 2017 New trial record
09 Aug 2017 According to Humanigen media release, company received clearance from the FDA in June 2017 for its Investigational New Drug (IND) application for benznidazole.
09 Aug 2017 According to Humanigen media release, analysis of the study has begun and anicipates its preliminary results by Oct 2017. Also, the final study report will expect in fourth quater of 2017.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com